| Year |
Citation |
Score |
| 2024 |
O'Connell CJ, Reeder EL, Hymore JA, Brown RS, Notorgiacomo GA, Collins SM, Gudelsky GA, Robson MJ. Transcriptomic dynamics governing serotonergic dysregulation in the dorsal raphe nucleus following mild traumatic brain injury. Experimental Neurology. 374: 114695. PMID 38246304 DOI: 10.1016/j.expneurol.2024.114695 |
0.353 |
|
| 2022 |
Pitzer EM, Sugimoto C, Regan SL, Gudelsky GA, Williams MT, Vorhees CV. Developmental deltamethrin: Sex-specific hippocampal effects in Sprague Dawley rats. Current Research in Toxicology. 3: 100093. PMID 36393872 DOI: 10.1016/j.crtox.2022.100093 |
0.416 |
|
| 2022 |
Collins SM, O'Connell CJ, Reeder EL, Norman SV, Lungani K, Gopalan P, Gudelsky GA, Robson MJ. Altered Serotonin 2A (5-HT) Receptor Signaling Underlies Mild TBI-Elicited Deficits in Social Dominance. Frontiers in Pharmacology. 13: 930346. PMID 35910378 DOI: 10.3389/fphar.2022.930346 |
0.387 |
|
| 2018 |
Arora P, Adams CH, Gudelsky G, DasGupta B, Desai PB. Plasma and brain pharmacokinetics of letrozole and drug interaction studies with temozolomide in NOD-scid gamma mice and sprague dawley rats. Cancer Chemotherapy and Pharmacology. PMID 30357450 DOI: 10.1007/S00280-018-3705-6 |
0.44 |
|
| 2017 |
Arora P, Huff C, Dave N, Gudelsky G, Desai P. EXTH-35. STEADY STATE BRAIN EXTRACELLULAR FLUID AND PLASMA PHARMACOKINETICS OF LETROZOLE IN SPRAGUE DAWLEY RATS: GENDER DIFFERENCES AND PROJECTIONS FOR TUMORAL DRUG LEVELS Neuro-Oncology. 19: vi79-vi80. DOI: 10.1093/Neuonc/Nox168.327 |
0.326 |
|
| 2016 |
Huff CL, Morano RL, Herman JP, Yamamoto BK, Gudelsky GA. MDMA decreases glutamic acid decarboxylase (GAD) 67-immunoreactive neurons in the hippocampus and increases seizure susceptibility: Role for glutamate. Neurotoxicology. PMID 27773601 DOI: 10.1016/J.Neuro.2016.10.011 |
0.311 |
|
| 2015 |
Collins SA, Huff C, Chiaia N, Gudelsky GA, Yamamoto BK. MDMA Increases Excitability in the Dentate Gyrus: Role of 5HT2A Receptor Induced PGE2 Signaling. Journal of Neurochemistry. PMID 26670377 DOI: 10.1111/Jnc.13493 |
0.384 |
|
| 2015 |
Collins SA, Gudelsky GA, Yamamoto BK. MDMA-induced loss of parvalbumin interneurons within the dentate gyrus is mediated by 5HT2A and NMDA receptors. European Journal of Pharmacology. 761: 95-100. PMID 25936514 DOI: 10.1016/J.Ejphar.2015.04.035 |
0.343 |
|
| 2014 |
Weber GF, Johnson BN, Yamamoto BK, Gudelsky GA. Effects of stress and MDMA on hippocampal gene expression. Biomed Research International. 2014: 141396. PMID 24511526 DOI: 10.1155/2014/141396 |
0.312 |
|
| 2013 |
Huff C, Bhide N, Schroering A, Yamamoto BK, Gudelsky GA. Effect of repeated exposure to MDMA on the function of the 5-HT transporter as assessed by synaptosomal 5-HT uptake. Brain Research Bulletin. 91: 52-7. PMID 23318273 DOI: 10.1016/J.Brainresbull.2013.01.003 |
0.745 |
|
| 2013 |
Isom AM, Gudelsky GA, Benoit SC, Richtand NM. Antipsychotic medications, glutamate, and cell death: a hidden, but common medication side effect? Medical Hypotheses. 80: 252-8. PMID 23265349 DOI: 10.1016/J.Mehy.2012.11.042 |
0.305 |
|
| 2013 |
Anneken JH, Cunningham JI, Collins SA, Yamamoto BK, Gudelsky GA. MDMA increases glutamate release and reduces parvalbumin-positive GABAergic cells in the dorsal hippocampus of the rat: role of cyclooxygenase. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 8: 58-65. PMID 23179355 DOI: 10.1007/S11481-012-9420-X |
0.797 |
|
| 2012 |
Anneken JH, Gudelsky GA. MDMA produces a delayed and sustained increase in the extracellular concentration of glutamate in the rat hippocampus. Neuropharmacology. 63: 1022-7. PMID 22842073 DOI: 10.1016/J.Neuropharm.2012.07.026 |
0.812 |
|
| 2012 |
Schaefer TL, Grace CE, Skelton MR, Graham DL, Gudelsky GA, Vorhees CV, Williams MT. Neonatal citalopram treatment inhibits the 5-HT depleting effects of MDMA exposure in rats. Acs Chemical Neuroscience. 3: 12-21. PMID 22582138 DOI: 10.1021/Cn2000553 |
0.489 |
|
| 2011 |
Roenker NL, Gudelsky G, Ahlbrand R, Bronson SL, Kern JR, Waterman H, Richtand NM. Effect of paliperidone and risperidone on extracellular glutamate in the prefrontal cortex of rats exposed to prenatal immune activation or MK-801. Neuroscience Letters. 500: 167-71. PMID 21699956 DOI: 10.1016/J.Neulet.2011.06.011 |
0.362 |
|
| 2011 |
Darvesh AS, Carroll RT, Geldenhuys WJ, Gudelsky GA, Klein J, Meshul CK, Van der Schyf CJ. In vivo brain microdialysis: advances in neuropsychopharmacology and drug discovery. Expert Opinion On Drug Discovery. 6: 109-127. PMID 21532928 DOI: 10.1517/17460441.2011.547189 |
0.658 |
|
| 2010 |
Herring NR, Gudelsky GA, Vorhees CV, Williams MT. (+)-Methamphetamine-induced monoamine reductions and impaired egocentric learning in adrenalectomized rats is independent of hyperthermia. Synapse (New York, N.Y.). 64: 773-85. PMID 20698032 DOI: 10.1002/Syn.20784 |
0.318 |
|
| 2010 |
Schaefer TL, Grace CE, Gudelsky GA, Vorhees CV, Williams MT. Effects on plasma corticosterone levels and brain serotonin from interference with methamphetamine-induced corticosterone release in neonatal rats. Stress (Amsterdam, Netherlands). 13: 469-80. PMID 20666642 DOI: 10.3109/10253891003786407 |
0.47 |
|
| 2010 |
Pachmerhiwala R, Bhide N, Straiko M, Gudelsky GA. Role of serotonin and/or norepinephrine in the MDMA-induced increase in extracellular glucose and glycogenolysis in the rat brain. European Journal of Pharmacology. 644: 67-72. PMID 20633550 DOI: 10.1016/J.Ejphar.2010.07.004 |
0.76 |
|
| 2010 |
Grace CE, Schaefer TL, Gudelsky GA, Williams MT, Vorhees CV. Neonatal methamphetamine-induced corticosterone release in rats is inhibited by adrenal autotransplantation without altering the effect of the drug on hippocampal serotonin. Neurotoxicology and Teratology. 32: 356-61. PMID 20153424 DOI: 10.1016/J.Ntt.2010.02.001 |
0.371 |
|
| 2009 |
Bhide NS, Lipton JW, Cunningham JI, Yamamoto BK, Gudelsky GA. Repeated exposure to MDMA provides neuroprotection against subsequent MDMA-induced serotonin depletion in brain. Brain Research. 1286: 32-41. PMID 19555677 DOI: 10.1016/J.Brainres.2009.06.042 |
0.766 |
|
| 2008 |
Herring NR, Schaefer TL, Gudelsky GA, Vorhees CV, Williams MT. Effect of +-methamphetamine on path integration learning, novel object recognition, and neurotoxicity in rats. Psychopharmacology. 199: 637-50. PMID 18509623 DOI: 10.1007/S00213-008-1183-Y |
0.32 |
|
| 2008 |
Gudelsky GA, Yamamoto BK. Actions of 3,4-methylenedioxymethamphetamine (MDMA) on cerebral dopaminergic, serotonergic and cholinergic neurons. Pharmacology, Biochemistry, and Behavior. 90: 198-207. PMID 18035407 DOI: 10.1016/J.Pbb.2007.10.003 |
0.487 |
|
| 2008 |
Schaefer TL, Skelton MR, Herring NR, Gudelsky GA, Vorhees CV, Williams MT. Short- and long-term effects of (+)-methamphetamine and (+/-)-3,4-methylenedioxymethamphetamine on monoamine and corticosterone levels in the neonatal rat following multiple days of treatment. Journal of Neurochemistry. 104: 1674-85. PMID 17996031 DOI: 10.1111/J.1471-4159.2007.05112.X |
0.352 |
|
| 2007 |
Straiko MM, Gudelsky GA, Coolen LM. Treatment with a serotonin-depleting regimen of MDMA prevents conditioned place preference to sex in male rats. Behavioral Neuroscience. 121: 586-93. PMID 17592950 DOI: 10.1037/0735-7044.121.3.586 |
0.765 |
|
| 2007 |
Straiko MM, Coolen LM, Zemlan FP, Gudelsky GA. The effect of amphetamine analogs on cleaved microtubule-associated protein-tau formation in the rat brain. Neuroscience. 144: 223-31. PMID 17084036 DOI: 10.1016/j.neuroscience.2006.08.073 |
0.8 |
|
| 2006 |
Straiko MM, Gudelsky GA, Coolen LM, Harrison R, Zemlan FP. Treatment with trimethyltin promotes the formation of cleaved tau in the rat brain. Journal of Neuroscience Research. 84: 1116-23. PMID 16917841 DOI: 10.1002/jnr.21002 |
0.763 |
|
| 2006 |
Nair SG, Gudelsky GA. Effect of a serotonin depleting regimen of 3,4-methylenedioxymethamphetamine (MDMA) on the subsequent stimulation of acetylcholine release in the rat prefrontal cortex. Brain Research Bulletin. 69: 382-7. PMID 16624669 DOI: 10.1016/j.brainresbull.2006.01.011 |
0.73 |
|
| 2006 |
Nair SG, Gudelsky GA. 3,4-Methylenedioxymethamphetamine enhances the release of acetylcholine in the prefrontal cortex and dorsal hippocampus of the rat. Psychopharmacology. 184: 182-9. PMID 16378215 DOI: 10.1007/s00213-005-0271-5 |
0.689 |
|
| 2005 |
Nair SG, Gudelsky GA. 3,4-Methylenedioxymethamphetamine (MDMA) enhances the release of acetylcholine by 5-HT4 and D1 receptor mechanisms in the rat prefrontal cortex. Synapse (New York, N.Y.). 58: 229-35. PMID 16206181 DOI: 10.1002/syn.20202 |
0.72 |
|
| 2005 |
Darvesh AS, Gudelsky GA. Evidence for a role of energy dysregulation in the MDMA-induced depletion of brain 5-HT. Brain Research. 1056: 168-75. PMID 16098955 DOI: 10.1016/j.brainres.2005.07.009 |
0.777 |
|
| 2005 |
Williams MT, Schaefer TL, Ehrman LA, Able JA, Gudelsky GA, Sah R, Vorhees CV. 3,4-Methylenedioxymethamphetamine administration on postnatal day 11 in rats increases pituitary-adrenal output and reduces striatal and hippocampal serotonin without altering SERT activity. Brain Research. 1039: 97-107. PMID 15781051 DOI: 10.1016/J.Brainres.2005.01.045 |
0.379 |
|
| 2005 |
Darvesh AS, Yamamoto BK, Gudelsky GA. Evidence for the involvement of nitric oxide in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in the rat brain. The Journal of Pharmacology and Experimental Therapeutics. 312: 694-701. PMID 15456837 DOI: 10.1124/Jpet.104.074849 |
0.762 |
|
| 2004 |
Skelton MR, Blankenmeyer TL, Gudelsky GA, Brown-Strittholt CA, Vorhees CV, Williams MT. Metyrapone attenuates the sequential learning deficits but not monoamine depletions following d,l-fenfluramine administration to adult rats. Synapse (New York, N.Y.). 54: 214-22. PMID 15484208 DOI: 10.1002/Syn.20077 |
0.35 |
|
| 2004 |
Nair SG, Gudelsky GA. Activation of 5-HT2 receptors enhances the release of acetylcholine in the prefrontal cortex and hippocampus of the rat. Synapse (New York, N.Y.). 53: 202-7. PMID 15266551 DOI: 10.1002/syn.20054 |
0.714 |
|
| 2004 |
Darvesh AS, Gudelsky GA. The relationship between hyperthermia and glycogenolysis in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in rats. Neurotoxicology and Teratology. 26: 571-7. PMID 15203179 DOI: 10.1016/j.ntt.2004.03.008 |
0.793 |
|
| 2004 |
Nair SG, Gudelsky GA. Protein kinase C inhibition differentially affects 3,4-methylenedioxymethamphetamine-induced dopamine release in the striatum and prefrontal cortex of the rat. Brain Research. 1013: 168-73. PMID 15193525 DOI: 10.1016/j.brainres.2004.04.007 |
0.701 |
|
| 2003 |
Hui AS, Striet JB, Gudelsky G, Soukhova GK, Gozal E, Beitner-Johnson D, Guo SZ, Sachleben LR, Haycock JW, Gozal D, Czyzyk-Krzeska MF. Regulation of catecholamines by sustained and intermittent hypoxia in neuroendocrine cells and sympathetic neurons. Hypertension. 42: 1130-6. PMID 14597643 DOI: 10.1161/01.Hyp.0000101691.12358.26 |
0.333 |
|
| 2003 |
Darvesh AS, Gudelsky GA. Activation of 5-HT2 receptors induces glycogenolysis in the rat brain. European Journal of Pharmacology. 464: 135-40. PMID 12620505 DOI: 10.1016/S0014-2999(03)01432-8 |
0.782 |
|
| 2003 |
Wallace TL, Vorhees CV, Zemlan FP, Gudelsky GA. Methamphetamine enhances the cleavage of the cytoskeletal protein tau in the rat brain. Neuroscience. 116: 1063-8. PMID 12617947 DOI: 10.1016/S0306-4522(02)00795-9 |
0.425 |
|
| 2003 |
Gudelsky GA, Yamamoto BK. Neuropharmacology and neurotoxicity of 3,4-methylenedioxymethamphetamine. Methods in Molecular Medicine. 79: 55-73. PMID 12506690 DOI: 10.1385/1-59259-358-5:55 |
0.369 |
|
| 2002 |
Darvesh AS, Shankaran M, Gudelsky GA. 3,4-Methylenedioxymethamphetamine produces glycogenolysis and increases the extracellular concentration of glucose in the rat brain. The Journal of Pharmacology and Experimental Therapeutics. 301: 138-44. PMID 11907167 DOI: 10.1124/Jpet.301.1.138 |
0.816 |
|
| 2001 |
Nixdorf WL, Burrows KB, Gudelsky GA, Yamamoto BK. Enhancement of 3,4-methylenedioxymethamphetamine neurotoxicity by the energy inhibitor malonate. Journal of Neurochemistry. 77: 647-54. PMID 11299327 DOI: 10.1046/J.1471-4159.2001.00262.X |
0.474 |
|
| 2001 |
Wallace TL, Gudelsky GA, Vorhees CV. Alterations in diurnal and nocturnal locomotor activity in rats treated with a monoamine-depleting regimen of methamphetamine or 3,4-methylenedioxymethamphetamine. Psychopharmacology. 153: 321-6. PMID 11271404 DOI: 10.1007/S002130000578 |
0.392 |
|
| 2001 |
Wallace TL, Vorhees CV, Gudelsky GA. Effects of lubeluzole on the methamphetamine-induced increase in extracellular glutamate and the long-term depletion of striatal dopamine. Synapse (New York, N.Y.). 40: 95-101. PMID 11252020 DOI: 10.1002/Syn.1030 |
0.376 |
|
| 2001 |
Shankaran M, Yamamoto BK, Gudelsky GA. Ascorbic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced hydroxyl radical formation and the behavioral and neurochemical consequences of the depletion of brain 5-HT. Synapse (New York, N.Y.). 40: 55-64. PMID 11170222 DOI: 10.1002/1098-2396(200104)40:1<55::Aid-Syn1026>3.0.Co;2-O |
0.762 |
|
| 2001 |
Wallace TL, Gudelsky GA, Vorhees CV. Neurotoxic regimen of methamphetamine produces evidence of behavioral sensitization in the rat. Synapse (New York, N.Y.). 39: 1-7. PMID 11071703 DOI: 10.1002/1098-2396(20010101)39:1<1::Aid-Syn1>3.0.Co;2-7 |
0.418 |
|
| 2000 |
Harold C, Wallace T, Friedman R, Gudelsky G, Yamamoto B. Methamphetamine selectively alters brain glutathione. European Journal of Pharmacology. 400: 99-102. PMID 10913590 DOI: 10.1016/S0014-2999(00)00392-7 |
0.307 |
|
| 2000 |
Burrows KB, Gudelsky G, Yamamoto BK. Rapid and transient inhibition of mitochondrial function following methamphetamine or 3,4-methylenedioxymethamphetamine administration. European Journal of Pharmacology. 398: 11-8. PMID 10856443 DOI: 10.1016/S0014-2999(00)00264-8 |
0.394 |
|
| 1999 |
Shankaran M, Yamamoto BK, Gudelsky GA. Involvement of the serotonin transporter in the formation of hydroxyl radicals induced by 3,4-methylenedioxymethamphetamine. European Journal of Pharmacology. 385: 103-10. PMID 10607865 DOI: 10.1016/S0014-2999(99)00728-1 |
0.761 |
|
| 1999 |
Gudelsky GA. Biphasic effect of sigma receptor ligands on the extracellular concentration of dopamine in the striatum of the rat. Journal of Neural Transmission (Vienna, Austria : 1996). 106: 849-56. PMID 10599867 DOI: 10.1007/s007020050205 |
0.325 |
|
| 1999 |
Shankaran M, Gudelsky GA. A neurotoxic regimen of MDMA suppresses behavioral, thermal and neurochemical responses to subsequent MDMA administration. Psychopharmacology. 147: 66-72. PMID 10591870 DOI: 10.1007/S002130051143 |
0.78 |
|
| 1999 |
Wallace TL, Gudelsky GA, Vorhees CV. Methamphetamine-induced neurotoxicity alters locomotor activity, stereotypic behavior, and stimulated dopamine release in the rat. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 9141-8. PMID 10516332 DOI: 10.1523/Jneurosci.19-20-09141.1999 |
0.377 |
|
| 1999 |
Shankaran M, Yamamoto BK, Gudelsky GA. Mazindol attenuates the 3,4-methylenedioxymethamphetamine-induced formation of hydroxyl radicals and long-term depletion of serotonin in the striatum. Journal of Neurochemistry. 72: 2516-22. PMID 10349862 DOI: 10.1046/J.1471-4159.1999.0722516.X |
0.76 |
|
| 1998 |
Shankaran M, Gudelsky GA. Effect of 3,4-methylenedioxymethamphetamine (MDMA) on hippocampal dopamine and serotonin. Pharmacology, Biochemistry, and Behavior. 61: 361-6. PMID 9802829 DOI: 10.1016/S0091-3057(98)00103-8 |
0.772 |
|
| 1996 |
Gudelsky GA. Effect of ascorbate and cysteine on the 3,4-methylenedioxymethamphetamine-induced depletion of brain serotonin. Journal of Neural Transmission (Vienna, Austria : 1996). 103: 1397-404. PMID 9029406 DOI: 10.1007/BF01271253 |
0.568 |
|
| 1996 |
Gudelsky GA, Nash JF. Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine: implications for serotonin-dopamine interactions. Journal of Neurochemistry. 66: 243-9. PMID 8522960 |
0.51 |
|
| 1995 |
Gudelsky GA. Effects of sigma receptor ligands on the extracellular concentration of dopamine in the striatum and prefrontal cortex of the rat. European Journal of Pharmacology. 286: 223-8. PMID 8608783 DOI: 10.1016/0014-2999(95)00415-8 |
0.305 |
|
| 1995 |
Yamamoto BK, Nash JF, Gudelsky GA. Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra. The Journal of Pharmacology and Experimental Therapeutics. 273: 1063-70. PMID 7791076 |
0.412 |
|
| 1994 |
Nichols DE, Frescas S, Marona-Lewicka D, Huang X, Roth BL, Gudelsky GA, Nash JF. 1-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)-2-aminopropane: a potent serotonin 5-HT2A/2C agonist. Journal of Medicinal Chemistry. 37: 4346-51. PMID 7996545 DOI: 10.1021/Jm00051A011 |
0.359 |
|
| 1994 |
Gudelsky GA, Yamamoto BK, Nash JF. Potentiation of 3,4-methylenedioxymethamphetamine-induced dopamine release and serotonin neurotoxicity by 5-HT2 receptor agonists. European Journal of Pharmacology. 264: 325-30. PMID 7698172 DOI: 10.1016/0014-2999(94)90669-6 |
0.54 |
|
| 1992 |
Gudelsky GA, Nwajei EE, Defife K, Nash JF. Interaction of amfonelic acid with antipsychotic drugs on dopaminergic neurons. Synapse (New York, N.Y.). 12: 304-11. PMID 1361248 DOI: 10.1002/syn.890120407 |
0.436 |
|
| 1992 |
Gudelsky GA, Nash JF. Neuroendocrinological and neurochemical effects of sigma ligands. Neuropharmacology. 31: 157-62. PMID 1348112 DOI: 10.1016/0028-3908(92)90026-L |
0.32 |
|
| 1990 |
Berry SA, Gudelsky GA. D1 receptors function to inhibit the activation of tuberoinfundibular dopamine neurons. The Journal of Pharmacology and Experimental Therapeutics. 254: 677-82. PMID 1974647 |
0.315 |
|
| 1990 |
Nash JF, Meltzer HY, Gudelsky GA. Effect of 3,4-methylenedioxymethamphetamine on 3,4-dihydroxyphenylalanine accumulation in the striatum and nucleus accumbens. Journal of Neurochemistry. 54: 1062-7. PMID 1689375 DOI: 10.1111/J.1471-4159.1990.Tb02358.X |
0.512 |
|
| 1989 |
Gudelsky GA, Berry SA, Meltzer HY. Neurotensin activates tuberoinfundibular dopamine neurons and increases serum corticosterone concentrations in the rat. Neuroendocrinology. 49: 604-9. PMID 2549437 DOI: 10.1159/000125176 |
0.33 |
|
| 1989 |
Nash JF, Meltzer HY, Gudelsky GA. Selective cross-tolerance to 5-HT1A and 5-HT2 receptor-mediated temperature and corticosterone responses. Pharmacology, Biochemistry, and Behavior. 33: 781-5. PMID 2533356 DOI: 10.1016/0091-3057(89)90470-X |
0.409 |
|
| 1988 |
Gudelsky GA, Koenig JI, Koyama T, Meltzer HY. Activity of tuberoinfundibular dopaminergic neurons and concentrations of serum prolactin in the rat following lithium administration. Psychopharmacology. 94: 92-6. PMID 3126532 DOI: 10.1007/Bf00735887 |
0.334 |
|
| 1988 |
Nash JF, Meltzer HY, Gudelsky GA. Antagonism of serotonin receptor mediated neuroendocrine and temperature responses by atypical neuroleptics in the rat. European Journal of Pharmacology. 151: 463-9. PMID 2905661 DOI: 10.1016/0014-2999(88)90544-4 |
0.455 |
|
| 1988 |
Koenig JI, Meltzer HY, Gudelsky GA. 5-Hydroxytryptamine1A receptor-mediated effects of buspirone, gepirone and ipsapirone. Pharmacology, Biochemistry, and Behavior. 29: 711-5. PMID 2901112 DOI: 10.1016/0091-3057(88)90192-X |
0.328 |
|
| 1988 |
Nash JF, Meltzer HY, Gudelsky GA. Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine. The Journal of Pharmacology and Experimental Therapeutics. 245: 873-9. PMID 2898523 |
0.468 |
|
| 1987 |
Passaro EA, Meltzer HY, Gudelsky GA. Effects of acute and chronic dexamethasone treatment on stimulated prolactin secretion in the rat. Endocrine Research. 13: 173-82. PMID 3497800 DOI: 10.3109/07435808709023671 |
0.324 |
|
| 1987 |
Gudelsky GA, Koenig JI, Simonovic M, Koyama T, Ohmori T, Meltzer HY. Differential effects of haloperidol, clozapine, and fluperlapine on tuberoinfundibular dopamine neurons and prolactin secretion in the rat. Journal of Neural Transmission. 68: 227-40. PMID 3104536 DOI: 10.1007/Bf02098500 |
0.352 |
|
| 1987 |
Gudelsky GA, Koenig JI, Meltzer HY. Selective desensitization of serotonin (5-HT) receptor-mediated hyperthermia by mianserin and other 5-HT antagonists. Neuropharmacology. 26: 707-12. PMID 2957607 DOI: 10.1016/0028-3908(87)90231-0 |
0.43 |
|
| 1987 |
Koenig JI, Gudelsky GA, Meltzer HY. Stimulation of corticosterone and beta-endorphin secretion in the rat by selective 5-HT receptor subtype activation. European Journal of Pharmacology. 137: 1-8. PMID 2956114 DOI: 10.1016/0014-2999(87)90175-0 |
0.395 |
|
| 1987 |
Gudelsky GA, Nash JF, Koenig JI, Meltzer HY. Neuroendocrine effects of typical and atypical antipsychotics in the rat Psychopharmacology Bulletin. 23: 483-486. |
0.312 |
|
| 1986 |
Gudelsky GA, Koenig JI, Meltzer HY. Thermoregulatory responses to serotonin (5-HT) receptor stimulation in the rat. Evidence for opposing roles of 5-HT2 and 5-HT1A receptors. Neuropharmacology. 25: 1307-13. PMID 2951611 DOI: 10.1016/0028-3908(86)90101-2 |
0.419 |
|
| 1986 |
Gudelsky GA, Koenig JI, Jackman H, Meltzer HY. Suppression of the hypo- and hyperthermic responses to 5-HT agonists following the repeated administration of monoamine oxidase inhibitors. Psychopharmacology. 90: 403-7. PMID 2947256 DOI: 10.1007/Bf00179199 |
0.45 |
|
| 1985 |
Meltzer HY, Simonovic M, Gudelsky GA. Phencyclidine-induced inhibition of rat prolactin secretion: increased portal blood dopamine. European Journal of Pharmacology. 110: 143-6. PMID 4007050 DOI: 10.1016/0014-2999(85)90042-1 |
0.382 |
|
| 1984 |
Gudelsky GA, Meltzer HY. Function of tuberoinfundibular dopamine neurons in pargyline- and reserpine-treated rats. Neuroendocrinology. 38: 51-5. PMID 6420718 DOI: 10.1159/000123865 |
0.313 |
|
| 1984 |
Simonovic M, Gudelsky GA, Meltzer HY. Effect of 8-hydroxy-2-(di-n-propylamino) tetralin on rat prolactin secretion. Journal of Neural Transmission. 59: 143-9. PMID 6233394 DOI: 10.1007/Bf01255412 |
0.505 |
|
| 1983 |
Gudelsky GA, Passaro E, Meltzer HY. Effect of two dopamine agonists, TL-99 and 3-PPP, on prolactin secretion in the rat. European Journal of Pharmacology. 90: 423-5. PMID 6884430 DOI: 10.1016/0014-2999(83)90565-4 |
0.314 |
|
| 1983 |
Meltzer HY, Simonovic M, Gudelsky GA. Effects of pirenperone and ketanserin on rat prolactin secretion in vivo and in vitro. European Journal of Pharmacology. 92: 83-9. PMID 6628538 DOI: 10.1016/0014-2999(83)90111-5 |
0.469 |
|
| 1983 |
Meltzer HY, Simonovic M, Gudelsky GA. Effect of yohimbine on rat prolactin secretion. The Journal of Pharmacology and Experimental Therapeutics. 224: 21-7. PMID 6294278 |
0.34 |
|
| 1982 |
Meltzer HY, Simonovic M, Fang VS, Gudelsky GA. Effect of buspirone on rat plasma prolactin levels and striatal dopamine turnover. Psychopharmacology. 78: 49-53. PMID 6128756 DOI: 10.1007/Bf00470587 |
0.345 |
|
| 1981 |
Ackerman GE, MacDonald PC, Gudelsky G, Mendelson CR, Simpson ER. Potentiation of epinephrine-induced lipolysis by catechol estrogens and their methoxy derivatives. Endocrinology. 109: 2084-8. PMID 6273128 DOI: 10.1210/Endo-109-6-2084 |
0.33 |
|
| 1980 |
Gudelsky GA, Porter JC. Release of dopamine from tuberoinfundibular neurons into pituitary stalk blood after prolactin or haloperidol administration. Endocrinology. 106: 526-9. PMID 7353525 DOI: 10.1210/endo-106-2-526 |
0.305 |
|
| 1978 |
Gudelsky GA, Annunziato L, Moore KE. Localization of the site of the haloperidol-induced, prolactin-mediated increase of dopamine turnover in the median eminence: studies in rats with complete hypothalamic deafferentations. Journal of Neural Transmission. 42: 181-92. PMID 690628 DOI: 10.1007/BF01675309 |
0.361 |
|
| 1977 |
Eikenburg DC, Ravitz AJ, Gudelsky GA, Moore KE. Effects of estrogen on prolactin and tuberoinfundibular dopaminergic neurons. Journal of Neural Transmission. 40: 235-44. PMID 881623 DOI: 10.1007/BF01257017 |
0.343 |
|
| 1977 |
Gudelsky GA, Annunziato L, Moore KE. Increase in dopamine content of the rat median eminence after long-term ovariectomy and its reversal by estrogen replacement. Endocrinology. 101: 1894-7. PMID 588327 DOI: 10.1210/endo-101-6-1894 |
0.374 |
|
| 1976 |
Gudelsky GA, Simpkins J, Mueller GP, Meites J, Moore KE. Selective actions of prolactin on catecholamine turnover in the hypothalamus and on serum LH and FSH. Neuroendocrinology. 22: 206-15. PMID 1028951 DOI: 10.1159/000122627 |
0.307 |
|
| Show low-probability matches. |